These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 9798342)

  • 1. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
    Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
    J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha.
    Konjević G; Jović V; Radulović S; Jelić S; Dzodić R; Spuzić I
    Neoplasma; 2001; 48(3):175-81. PubMed ID: 11583285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
    Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
    Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma.
    Nagatani T; Ichiyama S; Onuma R; Miyazawa M; Matsuzaki T; Miyagawa K; Baba N; Uchiyama M; Nakajima H
    Acta Derm Venereol; 1995 Nov; 75(6):494. PubMed ID: 8651034
    [No Abstract]   [Full Text] [Related]  

  • 5. [New combination chemotherapy for malignant melanoma--PAV(peplomycin, ACNU, VCR) therapy].
    Ikeda S; Tajima K; Miyasato H; Terakado T; Suzuki T; Miura T
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2198-204. PubMed ID: 6194756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of malignant melanoma].
    Ishihara K
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of malignant melanoma].
    Ishihara K; Yamazaki N; Asano K
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between functional capability and phenotypic characteristics of peripheral blood lymphocytes in patients with malignant melanoma].
    Konjević G; Jović V; Radomirović V; Spuzić I
    Glas Srp Akad Nauka Med; 2002; (47):121-36. PubMed ID: 16078447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly.
    Matsumoto T; Yokota K; Sawada M; Sakakibara A; Shibata S; Yasue S; Tomita Y; Yatsuya H; Akiyama M
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1514-20. PubMed ID: 23198869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
    Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients.
    Molenkamp BG; Sluijter BJ; van Leeuwen PA; Santegoets SJ; Meijer S; Wijnands PG; Haanen JB; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
    Clin Cancer Res; 2008 Jul; 14(14):4532-42. PubMed ID: 18628468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
    Nitta Y; Ikeya T; Sakakibara A; Tomita Y
    J Dermatol; 2011 Feb; 38(2):164-8. PubMed ID: 21269313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
    Maeda K; Miura S; Kawamura M; Jimbow K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perilesional treatment of metastatic melanoma with interferon-beta.
    Fujimura T; Okuyama R; Ohtani T; Ito Y; Haga T; Hashimoto A; Aiba S
    Clin Exp Dermatol; 2009 Oct; 34(7):793-9. PubMed ID: 19438554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic response of interferon-beta in malignant melanoma].
    Ishihara K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1010-6. PubMed ID: 2421645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of malignant melanoma responded to chemotherapy including DTIC and local injection of OK-432].
    Tsuji H; Sawada S; Okano R; Shimazaki C; Nakanishi S; Haruyama H; Isemura T; Nakagawa M; Ijichi H; Ueda K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1851-5. PubMed ID: 6964031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
    Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
    Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
    Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R
    J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
    Kretschmer L; Helmbold P; Emmert S; Marsch WC
    Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.